What happens during a C&P exam for Bladder Cancer (Agent Orange Presumptive)?

Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation. Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

← All Condition Guides

CLAIM RECON INTEL

Bladder Cancer (Agent Orange Presumptive)

Q: What are the VA rating percentages for Bladder Cancer (Agent Orange Presumptive)?

Bladder Cancer (Agent Orange Presumptive) (DC 7528) is rated at 100% under 38 CFR § 4.115b, DC 7528. Per § 4.115b DC 7528 verbatim: "Malignant neoplasms of the genitourinary system — 100." Per the verbatim NOTE: "Following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local reoccurrence or metastasis, rate on residuals as voiding dysfunction or renal dysfunction, whichever is predominant."

Q: What rates 100% for Bladder Cancer (Agent Orange Presumptive) under 38 CFR § 4.115b, DC 7528?

Under 38 CFR § 4.115b, DC 7528 (DC 7528), a 100% rating for Bladder Cancer (Agent Orange Presumptive) requires: Per § 4.115b DC 7528 verbatim: "Malignant neoplasms of the genitourinary system — 100." Per the verbatim NOTE: "Following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local reoccurrence or metastasis, rate on residuals as voiding dysfunction or renal dysfunction, whichever is predominant."

Q: What evidence do I need for a Bladder Cancer (Agent Orange Presumptive) VA claim?

Key evidence for a Bladder Cancer (Agent Orange Presumptive) claim includes: Service treatment records showing injury or complaints; Imaging (X-ray, MRI, CT); Range of motion measurements; Flare-up documentation per Sharp v. Shulkin; Buddy statements describing limitations. All evidence should document both the condition and its impact on daily functioning.

DC 752838 C.F.R. § 4.115b

Diagnostic Code

DC 7528

38 C.F.R. § 4.115b

Rating Range

100–100%

1 severity tier

Source

Verified

38 C.F.R. § 4.115b

Bladder Cancer (Agent Orange Presumptive) is rated by the U.S. Department of Veterans Affairs under DC 7528 of 38 CFR § 4.115b, DC 7528 across 1 severity tier (100%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.

Educational tool only. Not legal or medical advice. Not affiliated with the VA.

Overview

Malignant neoplasm of the urinary bladder. Added as a presumptive condition for Agent Orange exposure. Rated 100% during active disease. After treatment, rated on voiding dysfunction residuals.

Rating Criteria

100%

Per § 4.115b DC 7528 verbatim: "Malignant neoplasms of the genitourinary system — 100." Per the verbatim NOTE: "Following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local reoccurrence or metastasis, rate on residuals as voiding dysfunction or renal dysfunction, whichever is predominant."

03Key Evidence

—Service treatment records showing injury or complaints

—Imaging (X-ray, MRI, CT)

—Range of motion measurements

—Flare-up documentation per Sharp v. Shulkin

—Buddy statements describing limitations

—Prescription history

—Physical therapy records

—Employment impact documentation

04C&P Exam Tips

1Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation.

2Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

3Tell the examiner about flare-ups: frequency, duration, estimated ROM loss. Sharp v. Shulkin (2017) requires estimates.

4Request active, passive, weight-bearing, and non-weight-bearing ROM testing per Correia v. McDonald (2016).

5If you use assistive devices (brace, cane), bring them.

6Describe daily activity impact: work, sleep, household tasks.

Tools

Rating Calculator →Secondaries Explorer →C&P Exam Prep →PACT Act Scanner →2026 Rates →

Sources & Editorial

Rating criteria text quoted verbatim from 38 C.F.R. § 4.115b (Genitourinary system — diagnoses). Source verified 2026-05-27 by ClaimRecon Editorial Team against the Cornell Law CFR mirror; eCFR.gov is the authoritative government source.

View § 4.115b on eCFR →Cornell Law mirror →Editorial Standards →Suggest a correction →

EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIM RECON 2026

LOADING